High resolution proton NMR spectroscopy of multiple sclerosis lesions

Journal of Neurochemistry

Volumn 64, Issue 2, 1995, Pages 742-748

  Davies, Siân E C ^a,b   Newcombe, Jia ^a   Williams, Stephen R ^c   McDonald, W Ian ^b   Clark, John B ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c ROYAL COLLEGE OF SURGEONS OF ENGLAND   (United Kingdom)

Author keywords

Creatine; Multiple sclerosis; N Acetylaspartate; NMR spectroscopy

Indexed keywords

CHOLINE; CREATINE; INOSITOL;

ARTICLE; AUTOPSY; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; MULTIPLE SCLEROSIS; NEUROCHEMISTRY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; WHITE MATTER;

EID: 0028814565     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1995.64020742.x     Document Type: Article

References (45)

1. Arnold D. L., Matthews P. M., Francis G., and Antel J. (1990) Proton magnetic resonance spectroscopy of human brain in vivo in the evaluation of multiple sclerosis: assessment of the load of disease. Magn. Reson. Med. 14, 154-159.
2. Arnold D. L., Matthews P. M., Francis G. S., O'Connor J., and Antel J. P. (1992) Proton magnetic resonance spectroscopic imaging for metabolic characterization of demyelinating plaques. Ann. Neurol. 31, 235-241.
3. 1H spectrum of rat brain by two-dimensional shift correlated and J-resolved NMR spectroscopy. Magn. Reson. Med. 17, 285-303.
4. 1H-NMR spectrum of human brain. Proc. Soc. Magn. Reson. Med. 11, 651.
5. 1H-NMR spectroscopic studies of brain. Neurosci. Biobehav. Rev. 13, 23-31.
6. Brand A. and Leibfritz D. (1992) Metabolic markers in glial cells for differentiation of brain tissue. Proc. Soc. Magn. Reson. Med. 11, 649.
7. Bruhn H., Frahm J., Merboldt K. D., Hanickle W., Hanefeld F., Christen H. J., Kruse B., and Bauer H. J. (1992) Multiple sclerosis in children: cerebral metabolic alterations monitored by localized proton magnetic resonance spectroscopy in vivo. Ann. Neurol. 32, 140-150.
8. Cadoux-Hudson T. A. D., Kermode A., Rajagopalan B., Taylor D., Thompson A. J., Ormerod I. E. C., McDonald W. I., and Radda G. K. (1991) Biochemical changes within a multiple sclerosis plaque in vivo. J. Neurol. Neurosurg. Psychiatry 54, 1004-1006.
9. Christiansen P., Toft P., Larsson H. B. W., Stubgaard M., and Henriksen O. (1993) The concentration of N-acetyl aspartate, creatine plus phosphocreatine, and choline in different parts of the brain in adulthood and senium. Magn. Reson. Imaging 11, 799-806.
10. Confort-Gouny S., Vion-Dury J., Nicoli F., Dano P., Donnet A., Grazziani N., Gastaut J. L., Grisoli F., and Cozzone P. J. (1993) A multiparametric data analysis showing the potential of localized proton MR spectroscopy of the brain in the metabolic characterization of neurological diseases. J. Neurol. Sci. 118, 123-133.
11. Davie C. A., Hawkins C. P., Barker G. J., Brennan A., Tofts P. S., Miller D. H., and McDonald W. I. (1993) Detection of myelin breakdown products by proton magnetic resonance spectroscopy. Lancet 341, 630-631.
12. Davie C. A., Hawkins C. P., Barker G. J., Brennan A., Tofts P. S., Miller D. H., and McDonald W. I. (1994) Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions. Brain 117, 49-58.
13. Davies S. E. C., Newcombe J., Williams S. R., and Clark J. B. (1993a) Proton magnetic resonance spectroscopy of postmortem multiple sclerosis brain. Proc. Soc. Magn. Reson. Med. 12, 276.
14. Davies S. E. C., Newcombe J., Williams S. R., and Clark J. B. (1993b) Decreased N-acetyl aspartate in postmortem multiple sclerosis brain. (Abstr.) J. Neurochem. 61, (Suppl.), S131.
15. De Stefano N., Francis G., Antel J. P., and Arnold D. L. (1993) Reversible decreases of N-acetylaspartate in the brain of patients with relapsing remitting multiple sclerosis. Proc. Soc. Magn. Reson. Med. 12, 280.
16. 1H-NMR spectra of human brain in vivo. NMR Biomed. 4, 201-204.
17. Henning J., Pfister H., Ernst T., and Ott D. (1992) Direct absolute quantification of metabolites in the human brain with in vivo localized proton spectroscopy. NMR Biomed. 5, 193-199.
18. Klunk W. E., Panchalingam K., Moossy J., McClute R. J., and Pettegrew J. W. (1992) N-Acetyl-L-aspartate and other amino acid metabolites in Alzheimer's disease brain: a preliminary proton nuclear magnetic resonance study. Neurology 42, 1578-1585.
19. Koller K. J., Zaczek R., and Coyle J. T. (1984) N-Acetyl-aspartyl-glutamate: regional levels in rat brain and the effects of brain lesions as determined by a new HPLC method. J. Neurochem. 43, 1136-1142.
20. Koopmans R. A., Li D. K. B., Zhu G., Allen P. S., Penn A., and Paty D. W. (1993) Magnetic resonance spectroscopy of multiple sclerosis: in vivo detection of myelin breakdown product. Lancet 341, 631-632.
21. Kreis R., Ernst T., and Ross B. D. (1993) Absolute quantitation of water and metabolites in the human brain: II. Metabolite concentrations. J. Magn. Reson. [B] 102, 9-19.
22. Larsson H. B. W., Christiansen P., Jensen M., Frederiksen J., Heltberg A., Olesen J., and Henriksen O. (1991) Localized in vivo proton spectroscopy in the brain of patients with multiple sclerosis. Magn. Reson. Med. 22, 23-31.
23. Matthews P. M., Francis G., Antel J., and Arnold D. L. (1991) Proton magnetic resonance spectroscopy for metabolic characterization of plaques in multiple sclerosis. Neurology 41, 1251-1256.
24. McDonald W. I., Miller D. H., and Barnes D. (1992) The pathological evolution of multiple sclerosis. Neuropathol. Appl. Neurobiol. 18, 319-334.
25. Michaelis T., Helms G., Merboldt K. D., Hänickle W., Bruhn H., and Frahm J. (1993a) Identification of scyllo-inositol in proton NMR spectra of human brain in vivo. NMR Biomed. 6, 105-109.
26. Michaelis T., Merboldt K. D., Bruhn H., Hänickle W., and Frahm J. (1993b) Absolute concentrations of metabolites in the adult human brain in vivo: quantification of localized proton MR spectra. Radiology 187, 219-227.
27. Miller D. H., Austin S. J., Connelly A., Youl B. D., Gadian D. G., and McDonald W. I. (1991) Proton magnetic resonance spectroscopy of an acute and chronic lesion in multiple sclerosis. Lancet 337, 58-59.
28. Minderhoud J. M., Mooyaart E. L., Kamman R. L., Teelken A. W., Hoogstraten M. C., Vencken L. M., Gravenmade E. J., and van den Burg W. (1992) In vivo phosphorus magnetic resonance spectroscopy in multiple sclerosis. Arch. Neurol. 49, 161-165.
29. Moffett J. R., Namboodiri M. A. A., Cangro C. B., and Neale J. H. (1991) Immunohistochemical localization of N-acetylaspartate in rat brain. Neuroreport 2, 131-134.
30. Nadler J. V. and Cooper J. R. (1972) N-Acetyl-L-aspartic acid content of human neural tumours and bovine peripheral nervous tissues. J. Neurochem. 19, 313-319.
31. Newcombe J. and Cuzner M. L. (1993) Organization and research applications of the U. K. Multiple Sclerosis Society Tissue Bank, in How to Run a Brain Bank (Cruz-Sanchez F. F. and Tolosa E., eds). J. Neural Transm. 19 (Suppl.), 155-163.
32. Pan J. W., Hetherington H. P., Mason G. F., Whitaker J. N., and Poshost G. M. (1993) Evaluation of multiple sclerosis by high field spectroscopic imaging. Proc. Soc. Magn. Reson. Med. 12, 1552.
33. Patel T. B. and Clark J. B. (1979) Synthesis of N-acetyl-L-aspartate by rat brain mitochondria and its involvement in mitochondrial/ cytosolic carbon transport. Biochem. J. 184, 539-546.
34. Perry T. L., Hansen S., and Gandham S. S. (1981) Postmortem changes of amino compounds in human and rat brain. J. Neurochem. 36, 406-412.
35. Petroff O. A. C., Spencer D. D., Alger J. R., and Prichard J. W. (1989) High field proton magnetic resonance spectroscopy of human cerebrum obtained during surgery for epilepsy. Neurology 39, 1197-1202.
36. Poser C. M., Paty D. W., Scheinberg L., McDonald W. I., Davis F. A., Ebers G. C., Johnson K. P., Sibley W. A., Silberberg D. H., and Tourtellotte W. W. (1983) New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann. Neurol. 13, 227-231.
37. Preece N. E., Barker D., Butter C., Gadian D. G., and Urenjak J. (1993) Experimental allergic encephalomyelitis raises betaine levels in the spinal cord of strain 13 guinea pigs. NMR Biomed. 6, 194-200.
38. Richards T. L. (1991) Proton MR spectroscopy in multiple sclerosis: value in establishing diagnosis, monitoring progression and evaluating therapy. Am. J. Roentgenol. 157, 1073-1078.
39. Simmons M. L., Frondoza C. G., and Coyle J. T. (1991) Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies. Neuroscience 45, 37-45.
40. Tallan H. H., Moore S., and Stein W. H. (1956) N-Acetyl-L-aspartic acid in brain. J. Biol. Chem. 219, 257-264.
41. Urenjak J., Williams S. R., Gadian D. G., and Noble M. (1992) Specific expression on N-acetylaspartate in neurons, oligodendrocyte-type-2 astrocyte progenitors, and immature oligodendrocytes in vitro. J. Neurochem. 59, 55-61.
42. Urenjak J., Williams S. R., Gadian D. G., and Noble M. (1993) Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. J. Neurosci. 13, 981-989.
43. Van Hecke P., Marchai G., Johannik K., Demaeral P., Wilms G., Carton H., and Baert A. L. (1991) Human brain proton localized NMR spectroscopy in multiple sclerosis. Magn. Reson. Med. 18, 199-206.
44. Wolinsky J. S., Narayana P. A., and Fenstermacher M. J. (1990) Proton magnetic resonance spectroscopy in multiple sclerosis. Neurology 40, 1764-1769.
45. Zhu G., Allen P. S., Koopmans R., Li D. K., and Paty D. W. (1992) A marked elevation of inositol in MS lesions. Proc. Soc. Magn. Reson. Med. 11, 1948.